Clinical Trials on EBV Lymphomas
Total 8852 results
-
Chinese PLA General HospitalRecruitingEBV Infection | EBV-associated Hemophagocytic LymphohistiocytosisChina
-
Fondazione Italiana Linfomi - ETSActive, not recruitingIndolent B-Cell LymphomasFrance, Italy, Brazil, Austria, Portugal, Ukraine
-
University of MinnesotaCompletedCMV Viremia | EBV ViremiaUnited States
-
Peking UniversityUniversity of FloridaUnknown
-
ADC Therapeutics S.A.Withdrawn
-
Grupo Español de Linfomas y Transplante Autólogo...Completed
-
Ahmed Galal, MDWithdrawnB Cell LymphomasUnited States
-
University Hospital, Basel, SwitzerlandRecruitingEpstein-Barr Virus (EBV) InfectionSwitzerland
-
The First Hospital of Jilin UniversityUnknown
-
Institute of Liver and Biliary Sciences, IndiaWithdrawn
-
Yi-Hua ZhouThe First People's Hospital of Kunshan; Taixing People's Hospital; Fourth People... and other collaboratorsCompleted
-
Oncology Specialists, S.C.University of Illinois at ChicagoTerminatedNon-Hodgkin LymphomasUnited States
-
Fudan UniversityUnknownChemotherapy | T-Cell LymphomasChina
-
Dong-A University HospitalSamsung Medical Center; Asan Medical Center; Chonnam National University Hospital and other collaboratorsCompletedB-cell LymphomasKorea, Republic of
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy...CompletedNasopharyngeal Carcinoma | Hodgkin Lymphoma | Non-Hodgkin Lymphoma | Leiomyosarcoma | Lymphoproliferative Disorder | Severe Chronic Active EBV (SCAEBV)United States
-
Memorial Sloan Kettering Cancer CenterUniversity of NebraskaCompletedT-cell Lymphomas | Relapsed or RefractoryUnited States
-
Memorial Sloan Kettering Cancer CenterDana-Farber Cancer Institute; Stanford UniversityActive, not recruitingLymphoma | Relapsed/Refractory T-cell LymphomasUnited States
-
Samsung Medical CenterJanssen Medical AffairsCompletedNon-Hodgkin Lymphoma | Peripheral T-Cell LymphomasKorea, Republic of
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy...CompletedEpstein-Barr Virus-Related Hodgkin Lymphoma | Epstein-Barr Virus-Related Non-Hodgkin Lymphoma | EBV Positive Plasma Cell NeoplasmUnited States
-
Henan Cancer HospitalRecruitingRelapsed/Refractory B-cell LymphomasChina
-
National Health Research Institutes, TaiwanNational Taiwan University Hospital; China Medical University Hospital; Chang... and other collaboratorsNot yet recruitingPeripheral T-cell Lymphomas (PTCL)Taiwan
-
Bristol-Myers SquibbRecruitingRelapsed or Refractory T-cell LymphomasJapan
-
University of PennsylvaniaCompletedNon-Hodgkins Lymphoma (NHL) Patients, With CD19+B Cell LymphomasUnited States
-
Assistance Publique - Hôpitaux de ParisActive, not recruitingEpidermotropic T-cell LymphomasFrance
-
Lorenzo GallonBristol-Myers SquibbCompleted
-
Yogen SaunthararajahCompletedT-cell Lymphoma | Indolent B-cell Lymphoma | Aggressive B-cell Lymphoma | Non-Hodgkin's LymphomasUnited States
-
Nanjing NingQi Medicine Science and Technology...Jiangsu Cancer Institute & HospitalUnknownPeripheral T-cell LymphomasChina
-
Centre de Recherches et d'Etude sur la Pathologie...Completed
-
Aucta Pharmaceuticals, IncCompleted
-
Eureka Therapeutics Inc.Duke University; Duke Clinical Research InstituteTerminatedLymphomas Non-Hodgkin's B-CellUnited States
-
University Hospital, BrestTeva Pharmaceuticals USATerminatedCerebral Lymphoma B Cell RefractoryFrance
-
The Lymphoma Academic Research OrganisationCompletedNon-Hodgkin's LymphomasFrance
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.CompletedIndolent B-Cell Non-Hodgkin's LymphomasChina
-
Yale UniversityMerck Sharp & Dohme LLCTerminatedRelapsed Lymphomas | Refractory LymphomasUnited States
-
CHU de ReimsUnknownIndolent Cutaneous B Cell LymphomasFrance
-
National Cancer Institute (NCI)RecruitingImmune System Diseases | Lymphoproliferative Disorders | Peripheral T-cell LymphomasUnited States
-
Antengene Biologics LimitedRecruitingAdvanced Solid Tumors | B-cell Non-Hodgkin LymphomasUnited States
-
Dana-Farber Cancer InstituteHiberCell, Inc.CompletedRelapsed/Refractory Indolent B Cell Non-Hodgkin LymphomasUnited States
-
Affiliated Hospital of Nantong UniversityNot yet recruiting
-
Austin HealthMerck KGaA, Darmstadt, GermanyActive, not recruitingLymphomas Non-Hodgkin's B-CellAustralia
-
Beijing Friendship HospitalNot yet recruitingEBV | Hemophagocytic Lymphohistiocytoses | MetabonomicsChina
-
National Cancer Institute (NCI)Active, not recruitingPlasmablastic Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements | Refractory High Grade B-Cell... and other conditionsUnited States
-
Beijing Friendship HospitalNot yet recruiting
-
Ontario Clinical Oncology Group (OCOG)Sunnybrook Health Sciences Centre; Genzyme, a Sanofi CompanyCompletedAlemtuzumab and CHOP Chemotherapy for Aggressive Histological Peripheral T-Cell Lymphomas (ACCAPELA)Peripheral T-cell LymphomasCanada
-
IGM Biosciences, Inc.No longer availableRelapsed/Refractory Non-Hodgkin LymphomasAustralia, Korea, Republic of, Spain
-
Poitiers University HospitalCompleted
-
Fondazione Italiana Linfomi ONLUSCompletedB-Cell LymphomasItaly, Brazil
-
IRCCS San RaffaeleMundipharma K.K.Unknown
-
State Budgetary Healthcare Institution, National...UnknownRelapsed/Refractory Malignant LymphomasRussian Federation
-
National Cancer Institute (NCI)RecruitingKaposi Sarcoma | Viral Associated Malignancies | EBV/KSHV-associated LymphomasUnited States